Deepak Bhatt, MD, MPH, Director of Mount Sinai Heart, outlines the results for the HALO trial, explaining that a post hoc analysis revealed that a cluster of patients in one of the study arms was nonadherent; when results for adherent patients in this arm were calculated, they showed that systolic blood pressure was reduced. The presentation took place at the American College of Cardiology's Annual Scientific Session Together With World Congress of Cardiology on Saturday, March 4.
